当前位置： SCI文献检索 > EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING期刊下所有文献 > Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.

Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.

Abstract：

PURPOSE:We present our first clinical experience with O-(2-18F-fluoroethyl)-L-tyrosine (FET) PET in patients with high-grade glioma treated with various neurooncological therapies including tumour-treating fields (TTFields) for the differentiation of tumour progression from treatment-related changes. METHODS:We retrospectively assessed 12 patients (mean age 51 ± 12 years, range 33-72 years) with high-grade glioma (11 glioblastomas, 1 gliosarcoma) in whom the treatment regimen included TTFields and who had undergone FET PET scans for differentiation of tumour progression from treatment-related changes. Mean and maximum tumour-to-brain ratios (TBRmean, TBRmax) were calculated. The definitive diagnosis (tumour progression or posttherapeutic changes) was confirmed either by histopathology (4 of 12 patients) or on clinical follow-up. RESULTS:In all nine patients with confirmed tumour progression, the corresponding FET PET showed increased uptake (TBRmax 3.5 ± 0.6, TBRmean 2.7 ± 0.7). In one of these nine patients, FET PET was consistent with treatment-related changes, whereas standard MRI showed a newly diagnosed contrast-enhancing lesion. In two patients treated solely with TTFields without any other concurrent neurooncological therapy, serial FET PET revealed a decrease in metabolic activity over a follow-up of 6 months or no FET uptake without any signs of tumour progression or residual tumour on conventional MRI. CONCLUSION:FET PET may add valuable information in monitoring therapy in individual patients with high-grade glioma undergoing neurooncological treatment including TTFields.

journal_name

Eur J Nucl Med Mol Imaging

journal_title

European journal of nuclear medicine and molecular imaging

authors

Ceccon G,Lazaridis L,Stoffels G,Rapp M,Weber M,Blau T,Lohmann P,Kebir S,Herrmann K,Fink GR,Langen KJ,Glas M,Galldiks N

doi

10.1007/s00259-018-3992-5

subject

Has Abstract

pub_date

2018-07-01 00:00:00

pages

1626-1635

issue

9

eissn

1619-7070

issn

1619-7089

pii

10.1007/s00259-018-3992-5

journal_volume

45

pub_type

杂志文章

相关文献

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING文献大全
  • Gallium-labelled peptides for imaging of inflammation.

    abstract：:Inflammation plays a major role in the development of many diseases. This review article summarizes recent research in the field of in vivo imaging of inflammation. Novel methodologies using PET with (68)Ga peptides targeting, for example, vascular adhesion protein 1 are discussed. ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s00259-011-1987-6

    authors： Roivainen A,Jalkanen S,Nanni C

    更新日期：2012-02-01 00:00:00

  • Investigation into the mechanisms of vagus nerve stimulation for the treatment of intractable epilepsy, using 99mTc-HMPAO SPET brain images.

    abstract：:Vagus nerve stimulation (VNS) has gained recognition as a treatment for refractory epilepsies where surgical treatment is not possible. While it appears that this treatment is effective in some patients, the mechanism of action is not clearly understood. The purpose of this study was to clarify findings of other posit...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-002-1026-8

    authors： Barnes A,Duncan R,Chisholm JA,Lindsay K,Patterson J,Wyper D

    更新日期：2003-02-01 00:00:00

  • Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[123I] p-iodoamphetamine.

    abstract：:We evaluated an autoradiographic (ARG) method to calculate regional cerebral blood flow (rCBF) sequentially before and after an acetazolamide (ACZ) challenge in a single session of single-photon emission tomography (SPET) with two injections of N-isopropyl-[(123)I] p-iodoamphetamine (IMP). The method uses a table look...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-003-1180-7

    authors： Nishizawa S,Iida H,Tsuchida T,Ito H,Konishi J,Yonekura Y

    更新日期：2003-07-01 00:00:00

  • Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.

    abstract：PURPOSE:The aim of this study was to investigate the feasibility of assessing dopamine transporter binding after treatment with methylphenidate in the rat using a recently developed high-resolution small animal single-photon emission computed tomograph (TierSPECT) and [123I]FP-CIT. METHODS:[123I]FP-CIT was administere...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-004-1615-9

    authors： Nikolaus S,Wirrwar A,Antke C,Arkian S,Schramm N,Müller HW,Larisch R

    更新日期：2005-03-01 00:00:00

  • Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications.

    abstract：:Techniques from the field of artificial intelligence, and more specifically machine (deep) learning methods, have been core components of most recent developments in the field of medical imaging. They are already being exploited or are being considered to tackle most tasks, including image reconstruction, processing (...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s00259-019-04373-w

    authors： Visvikis D,Cheze Le Rest C,Jaouen V,Hatt M

    更新日期：2019-12-01 00:00:00

  • Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease.

    abstract：PURPOSE:To determine clinical predictors and accuracy of (123)I-FP-CIT SPECT imaging in the differentiation of drug-induced parkinsonism (DIP) and Parkinson's disease (PD). METHODS:Several clinical features and (123)I-FP-CIT SPECT images in 32 patients with DIP, 25 patients with PD unmasked by antidopaminergic drugs (...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-009-1289-4

    authors： Diaz-Corrales FJ,Sanz-Viedma S,Garcia-Solis D,Escobar-Delgado T,Mir P

    更新日期：2010-03-01 00:00:00

  • Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET.

    abstract：PURPOSE:Quantitative image reconstruction in positron emission tomography (PET) requires an accurate attenuation map of the object under study for the purpose of attenuation correction. Current dual-modality PET/CT systems offer significant advantages over stand-alone PET, including decreased overall scanning time and ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-006-0086-6

    authors： Ay MR,Zaidi H

    更新日期：2006-11-01 00:00:00

  • Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET.

    abstract：PURPOSE:The future significance of peptide radiopharmaceuticals in diagnostic imaging with PET will be dependent on methodological aspects, as well as other requirements such as availability of the radionuclide and cost-effectiveness of its production. The aim of this study was to evaluate whether recent improvements i...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-004-1582-1

    authors： Henriksen G,Schottelius M,Poethko T,Hauser A,Wolf I,Schwaiger M,Wester HJ

    更新日期：2004-12-01 00:00:00

  • Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

    abstract：:The last 25 years have seen major changes in the imaging investigation and subsequent management of patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL); accurate staging is vital for prognostication and treatment in both, and particularly in HD. The choice of imaging modality for staging depends on i...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s00259-003-1159-4

    authors： Vinnicombe SJ,Reznek RH

    更新日期：2003-06-01 00:00:00

  • FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.

    abstract：PURPOSE:Although resynchronisation therapy (CRT) is a promising addition to heart failure therapy, a substantial number of patients do not respond to CRT. As FDG PET has routinely been used for prediction of improvement after revascularisation in ischaemic cardiomyopathy, it was hypothesised that there is also a relati...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-006-0235-y

    authors： van Campen CM,Visser FC,van der Weerdt AP,Knaapen P,Comans EF,Lammertsma AA,de Cock CC,Visser CA

    更新日期：2007-03-01 00:00:00

  • Long-term prognostic implications of myocardial perfusion imaging in octogenarians: an all-comer, cohort study.

    abstract：PURPOSE:Evaluation of the long-term prognostic value of myocardial perfusion imaging (MPI) in octogenarians. METHODS:Six hundred and twenty-nine octogenarians [51% previous myocardial infarction (MI) or revascularization] who underwent single-isotope MPI (78% 201Tl, 22% 99mTc-tetrofosmin) with exercise (38% Bruce, 2% ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-017-3739-8

    authors： Katsikis A,Theodorakos A,Manira V,Papaioannou S,Kolovou G,Voudris V,Koutelou M

    更新日期：2017-08-01 00:00:00

  • PET and SPET tracers for mapping the cardiac nervous system.

    abstract：:The human cardiac nervous system consists of a sympathetic and a parasympathetic branch with (-)-norepinephrine and acetylcholine as the respective endogenous neurotransmitters. Dysfunction of the cardiac nervous system is implicated in various types of cardiac disease, such as heart failure, myocardial infarction and...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章,评审

    doi：10.1007/s002590100640

    authors： Langer O,Halldin C

    更新日期：2002-03-01 00:00:00

  • Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up.

    abstract：PURPOSE:The aim of this study is to report on a collective of 20 children from Belarus who had developed papillary thyroid carcinoma with pulmonary metastases after the Chernobyl disaster. In all children fractionated radioiodine therapy (RIT) was ceased before achieving complete remission due to a lack of further effe...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00259-010-1669-9

    authors： Biko J,Reiners C,Kreissl MC,Verburg FA,Demidchik Y,Drozd V

    更新日期：2011-04-01 00:00:00

  • Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety.

    abstract：PURPOSE:The objective of this study was to investigate and present the early results on the efficacy, safety, and quality of life of 225Ac-DOTATATE targeted alpha therapy (TAT) in patients with advanced, progressive, 177Lu-DOTATATE refractory, and somatostatin receptor (SSTR) expressing metastatic GEP-NETs. METHODS:In...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-019-04567-2

    authors： Ballal S,Yadav MP,Bal C,Sahoo RK,Tripathi M

    更新日期：2020-04-01 00:00:00

  • [18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration.

    abstract：PURPOSE:To study the feasibility of the in vivo [18F]-DPA-714 TSPO positron emission tomography (PET) to detect glial activation in a rat model of progressive parkinsonism induced by viral-mediated overexpression of A53T mutated human α-synuclein (hα-syn) in the substantia nigra pars compacta (SNpc). METHODS:We conduc...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-020-04772-4

    authors： Rodríguez-Chinchilla T,Quiroga-Varela A,Molinet-Dronda F,Belloso-Iguerategui A,Merino-Galan L,Jimenez-Urbieta H,Gago B,Rodriguez-Oroz MC

    更新日期：2020-10-01 00:00:00

  • Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.

    abstract：PURPOSE:This study aimed at identifying prior therapy dosimetric parameters using 99mTc-labeled macro-aggregates of albumin (MAA) that are associated with contralateral hepatic hypertrophy occurring after unilobar radioembolization of hepatocellular carcinoma (HCC) performed with 90Y-loaded glass microspheres. METHODS...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-017-3845-7

    authors： Palard X,Edeline J,Rolland Y,Le Sourd S,Pracht M,Laffont S,Lenoir L,Boudjema K,Ugen T,Brun V,Mesbah H,Haumont LA,Loyer P,Garin E

    更新日期：2018-03-01 00:00:00

  • 18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer.

    abstract：PURPOSE:The study aims to investigate the role of 18F-alfatide positron emission tomography/computed tomography (PET/CT) in predicting the short-term outcome of concurrent chemoradiotherapy (CCRT) in patients with advanced non-small cell lung cancer (NSCLC). METHODS:Eighteen patients with advanced NSCLC had undergone ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-016-3505-3

    authors： Luan X,Huang Y,Gao S,Sun X,Wang S,Ma L,Teng X,Lu H,Yu J,Yuan S

    更新日期：2016-12-01 00:00:00

  • Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants.

    abstract：PURPOSE:To assess the binding of the PET tracer [18F]THK5351 in patients with different primary progressive aphasia (PPA) variants and its correlation with clinical deficits. The majority of patients with nonfluent variant (NFV) and logopenic variant (LV) PPA have underlying tauopathy of the frontotemporal lobar or Alz...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-018-4075-3

    authors： Schaeverbeke J,Evenepoel C,Declercq L,Gabel S,Meersmans K,Bruffaerts R,Adamczuk K,Dries E,Van Bouwel K,Sieben A,Pijnenburg Y,Peeters R,Bormans G,Van Laere K,Koole M,Dupont P,Vandenberghe R

    更新日期：2018-12-01 00:00:00

  • TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma.

    abstract：OBJECTIVE:The 18-kDa mitochondrial translocator protein (TSPO) was reported to be upregulated in gliomas. 18F-GE-180 is a novel 3rd generation TSPO receptor ligand with improved target-to-background contrast compared to previous tracers. In this pilot study, we compared PET imaging with 18F-GE-180 and MRI of patients w...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-017-3799-9

    authors： Albert NL,Unterrainer M,Fleischmann DF,Lindner S,Vettermann F,Brunegraf A,Vomacka L,Brendel M,Wenter V,Wetzel C,Rupprecht R,Tonn JC,Belka C,Bartenstein P,Niyazi M

    更新日期：2017-12-01 00:00:00

  • Dynamic perfusion patterns in temporal lobe epilepsy.

    abstract：PURPOSE:To investigate dynamic ictal perfusion changes during temporal lobe epilepsy (TLE). METHODS:We investigated 37 patients with TLE by ictal and interictal SPECT. All ictal injections were performed within 60 s of seizure onset. Statistical parametric mapping was used to analyse brain perfusion changes and tempor...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-008-1040-6

    authors： Dupont P,Zaknun JJ,Maes A,Tepmongkol S,Vasquez S,Bal CS,Van Paesschen W,Carpintiero S,Locharernkul C,Dondi M

    更新日期：2009-05-01 00:00:00

  • Novel adversarial semantic structure deep learning for MRI-guided attenuation correction in brain PET/MRI.

    abstract：OBJECTIVE:Quantitative PET/MR imaging is challenged by the accuracy of synthetic CT (sCT) generation from MR images. Deep learning-based algorithms have recently gained momentum for a number of medical image analysis applications. In this work, a novel sCT generation algorithm based on deep learning adversarial semanti...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-019-04380-x

    authors： Arabi H,Zeng G,Zheng G,Zaidi H

    更新日期：2019-12-01 00:00:00

  • Indication of retrograde tau spreading along Braak stages and functional connectivity pathways.

    abstract：PURPOSE:Tau pathology progression in Alzheimer's disease (AD) is explained through the network degeneration hypothesis and the neuropathological Braak stages; however, the compatibility of these models remains unclear. METHODS:We utilized [18F]AV-1451 tau-PET scans of 39 subjects with AD and 39 sex-matched amyloid-neg...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-020-05183-1

    authors： Seemiller J,Bischof GN,Hoenig MC,Tahmasian M,van Eimeren T,Drzezga A,and the Alzheimer’s Disease Neuroimaging Initiative.

    更新日期：2021-01-18 00:00:00

  • [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.

    abstract：PURPOSE:The serotonin-1A (5-HT(1A)) receptor is implicated in the pathophysiology of major neuropsychiatric disorders. Thus, the functional imaging of 5-HT(1A) receptors by positron emission tomography (PET) may contribute to the understanding of its role in those pathologies and their therapeutics. These receptors exi...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-009-1274-y

    authors： Lemoine L,Verdurand M,Vacher B,Blanc E,Le Bars D,Newman-Tancredi A,Zimmer L

    更新日期：2010-03-01 00:00:00

  • In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients.

    abstract：PURPOSE:Imaging the 18-kDa translocator protein (TSPO) is considered a potential tool for in vivo evaluation of microglial activation and neuroinflammation in the early stages of Alzheimer's disease (AD). ((R)-1-(2-chlorophenyl)-N-[(11)C]-methyl-N-(1-methylpropyl)-3-isoquinoline caboxamide ([(11)C]-(R)-PK11195) has bee...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-013-2359-1

    authors： Varrone A,Mattsson P,Forsberg A,Takano A,Nag S,Gulyás B,Borg J,Boellaard R,Al-Tawil N,Eriksdotter M,Zimmermann T,Schultze-Mosgau M,Thiele A,Hoffmann A,Lammertsma AA,Halldin C

    更新日期：2013-06-01 00:00:00

  • Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI.

    abstract：BACKGROUND:Following brain cancer treatment, the capacity of anatomical MRI to differentiate neoplastic tissue from treatment-related changes (e.g., pseudoprogression) is limited. This study compared apparent diffusion coefficients (ADC) obtained by diffusion-weighted MRI (DWI) with static and dynamic parameters of O-(...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-019-04384-7

    authors： Werner JM,Stoffels G,Lichtenstein T,Borggrefe J,Lohmann P,Ceccon G,Shah NJ,Fink GR,Langen KJ,Kabbasch C,Galldiks N

    更新日期：2019-08-01 00:00:00

  • Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes.

    abstract：PURPOSE:Radioguided sentinel lymph node biopsy (SLNB) is the standard of care in breast cancer and melanoma. Additional preoperative Single-photon emission computed tomography (SPECT/CT) for improved anatomical co-registration of the SLNs causes additional radiation exposure and is time-consuming and expensive. The aim...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-016-3443-0

    authors： Bluemel C,Safak G,Cramer A,Wöckel A,Gesierich A,Hartmann E,Schmid JS,Kaiser F,Buck AK,Herrmann K

    更新日期：2016-12-01 00:00:00

  • Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types.

    abstract：PURPOSE:Fusion dual-tracer SPECT imaging enables physiological rather than morphological voxel-based partitioning and dosimetry for (90)Y hepatic radioembolization (RE). We evaluated its prognostic value in a large heterogeneous cohort of patients with extensive hepatic malignancy. METHODS:A total of 122 patients with...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-015-3048-z

    authors： Lam MG,Banerjee A,Goris ML,Iagaru AH,Mittra ES,Louie JD,Sze DY

    更新日期：2015-07-01 00:00:00

  • PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.

    abstract：PURPOSE:Tumour hypoxia is linked to treatment resistance. Positron emission tomography (PET) using hypoxia tracers such as fluoroazomycin arabinoside (FAZA) may allow identification of patients with hypoxic tumours and the monitoring of the efficacy of hypoxia-targeting treatment. Since hypoxia PET is characterized by ...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-012-2258-x

    authors： Busk M,Mortensen LS,Nordsmark M,Overgaard J,Jakobsen S,Hansen KV,Theil J,Kallehauge JF,D'Andrea FP,Steiniche T,Horsman MR

    更新日期：2013-01-01 00:00:00

  • Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.

    abstract：PURPOSE:Familial adenomatous polyposis (FAP) is characterised by colonic and duodenal adenomatous polyps that carry a risk of malignant transformation. Malignant degeneration of duodenal adenomas is difficult to detect. We speculated that 2-((18)F)-fluoro-2-deoxy-D: -glucose positron emission tomography (FDG-PET) might...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-005-1955-0

    authors： van Kouwen MC,Drenth JP,van Krieken JH,van Goor H,Friederich P,Oyen WJ,Nagengast FM

    更新日期：2006-03-01 00:00:00

  • In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT.

    abstract：PURPOSE:The objective of this study was to evaluate the potential of PEGylated (64)Cu-liposomes in clinical diagnostic positron emission tomography (PET) imaging and PEGylated (177)Lu-liposomes in internal tumor radiotherapy through in vivo characterization and dosimetric analysis in a human xenograft mouse model. MET...

    journal_title：European journal of nuclear medicine and molecular imaging

    pub_type： 杂志文章

    doi：10.1007/s00259-015-3272-6

    authors： Petersen AL,Henriksen JR,Binderup T,Elema DR,Rasmussen PH,Hag AM,Kjær A,Andresen TL

    更新日期：2016-05-01 00:00:00